Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that ...

The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...

New Delhi: Inflammatory Bowel Disease (IBD) is a chronic condition characterized by ... Dr. Praveen Sharma described the ...

ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting the repair of the ...

Inflammatory bowel disease (IBD) affects an estimated 1.6 million Americans. In fact, there are more than 70,000 new cases of ...

In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the ...

Potential for efficacy in this drug class was supported by studies ... there is a pressing need for new therapies as the incidence of IBD continues to increase. Selectively blocking the action ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

The chronic condition can cause abdominal pain, diarrhea, bloody stools and fatigue. New research suggests it affects more ...

Veterans with inflammatory bowel disease (IBD) prioritize shared decision-making ... Biosimilar switching programs offer the ...

Discover how β-ionone offers relief from ulcerative colitis by enhancing gut health, reducing inflammation, and restoring ...

Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal disease in decades.